259 related articles for article (PubMed ID: 15765203)
41. Differences in current clinical features of diploid and triploid hydatidiform mole.
Niemann I; Petersen LK; Hansen ES; Sunde L
BJOG; 2007 Oct; 114(10):1273-7. PubMed ID: 17655732
[TBL] [Abstract][Full Text] [Related]
42. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
[TBL] [Abstract][Full Text] [Related]
43. Guidelines following hydatidiform mole: a reappraisal.
Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
[TBL] [Abstract][Full Text] [Related]
44. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
45. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):147-54. PubMed ID: 8035369
[TBL] [Abstract][Full Text] [Related]
46. Stability of inhibin A and unconjugated oestriol in the second trimester of pregnancy.
Brown LF; Shearing CH; Tydeman G
Ann Clin Biochem; 2011 Jan; 48(Pt 1):72-4. PubMed ID: 21115569
[TBL] [Abstract][Full Text] [Related]
47. Cell-free fetal DNA levels in pregnancies conceived by IVF.
Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
[TBL] [Abstract][Full Text] [Related]
48. Inhibin: a new circulating marker of hydatidiform mole?
Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
[TBL] [Abstract][Full Text] [Related]
49. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
50. Maternal serum biochemical screening for pregnancy complications other than aneuploidy.
Pahal GS; Jauniaux E
Curr Opin Obstet Gynecol; 1997 Dec; 9(6):379-86. PubMed ID: 9425582
[TBL] [Abstract][Full Text] [Related]
51. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
Christiansen M; Nørgaard-Pedersen B
Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
[TBL] [Abstract][Full Text] [Related]
52. Stability of first- and second-trimester serum markers after storage and shipment.
Lambert-Messerlian GM; Eklund EE; Malone FD; Palomaki GE; Canick JA; D'Alton ME
Prenat Diagn; 2006 Jan; 26(1):17-21. PubMed ID: 16378319
[TBL] [Abstract][Full Text] [Related]
53. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
[TBL] [Abstract][Full Text] [Related]
54. Complete hydatidiform mole and surviving coexistent twin--a case report.
Japaraj RP; Sivalingam N
Singapore Med J; 2000 Mar; 41(3):126-8. PubMed ID: 11063197
[TBL] [Abstract][Full Text] [Related]
55. Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review.
Lin LH; Maestá I; Braga A; Sun SY; Fushida K; Francisco RPV; Elias KM; Horowitz N; Goldstein DP; Berkowitz RS
Gynecol Oncol; 2017 Apr; 145(1):88-95. PubMed ID: 28132722
[TBL] [Abstract][Full Text] [Related]
56. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
57. Placental pathology casebook. Complete hydatidiform mole with coexistent term twin pregnancy.
Albers E; Daneshmand S; Hull A
J Perinatol; 2001; 21(1):72-5. PubMed ID: 11268872
[TBL] [Abstract][Full Text] [Related]
58. Serum relaxin in patients with hydatidiform mole.
Seki K; Uesato T; Tabei T; Kato K
Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
[TBL] [Abstract][Full Text] [Related]
59. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
60. First trimester diagnosis of partial mole.
Phupong V; Triratanachat S; Promchainant C; Ultchaswadi P
Arch Gynecol Obstet; 2005 Sep; 272(3):235-7. PubMed ID: 15875207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
